US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by MindWalk Holdings Corp.

News headline image
MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
The Biology Came First.
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Announces Share Repurchase Program
From MindWalk Holdings Corp.
Via Business Wire
Tickers HYFT
News headline image
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
From MindWalk Holdings Corp.
Via Business Wire